her-2与乳腺癌的关系
本文档由 kyan 分享于2010-11-16 21:36
HER-2/neu, overexpressed in breast cancer, is a source of immunogenic peptides that include GP2and E75. Phase 2 testing of E75 as an adjuvant vaccine has suggested a clinical benefit. GP2, derived from the trans-membrane portion of HER-2/neu, has differing binding characteristics and may be more immunogenic than E75.Results of the first phase 1 trial of ..
分享：
君，已阅读到文档的结尾了呢~~